Hyshka, K and Dong, K and Meador, Karine and Speed, K and Abele, B and LeBlanc, S and McFarlane, Anne and McNeil, R and Salokangas, E and Schoen, E and Wild, TC (2020) Supporting people who use substances in shelter settings during the COVID-19 pandemic. Edmonton; Alberta: Canadian Research Initiative in Substance Misuse.
Preview | Title | Contact |
---|---|---|
|
PDF (Supporting people who use substances in shelter settings during the COVID-19 pandemic)
- Published Version
2MB |
This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID‑19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID‑19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.
The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.
B Substances > Alcohol
B Substances > Tobacco (cigarette smoking)
B Substances > Sedatives, hypnotics or tranquillisers (CNS depressants)
B Substances > New (novel) psychoactive substances > Benzodiazepines
G Health and disease > Substance use disorder (addiction) > Alcohol use disorder
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
L Social psychology and related concepts > Physical context, location or place > Safe spaces (injecting facilities / centre / consumption rooms)
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Canada
Repository Staff Only: item control page